Patents by Inventor Yunpeng Ye

Yunpeng Ye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Matrix Metalloproteinase Inhibitors and Imaging Agents, And Methods Using Same
    Publication number: 20220194930
    Abstract: The present invention provides certain compounds, or salts or solvates thereof, which can be used as matrix metalloproteinase-targeted inhibitors or imaging agents.
    Type: Application
    Filed: March 11, 2022
    Publication date: June 23, 2022
    Inventors: Mehran SADEGHI, Yunpeng YE, Hye-Yeong KIM, Henry(Yiyun) HUANG, Jakub TOCZEK
  • Matrix metalloproteinase inhibitors and imaging agents, and methods using same
    Patent number: 11286251
    Abstract: The present invention provides certain compounds, or salts or solvates thereof, which can be used as matrix metalloproteinase-targeted inhibitors or imaging agents.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: March 29, 2022
    Assignees: YALE UNIVERSITY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
    Inventors: Mehran Sadeghi, Yunpeng Ye, Hye-Yeong Kim, Henry(Yiyun) Huang, Jakub Toczek
  • Matrix Metalloproteinase Inhibitors and Imaging Agents, And Methods Using Same
    Publication number: 20200283428
    Abstract: The present invention provides certain compounds, Formula (I), or salts or solvates thereof, which can be used as matrix metalloproteinase-targeted inhibitors or imaging agents.
    Type: Application
    Filed: April 7, 2017
    Publication date: September 10, 2020
    Inventors: Mehran SADEGHI, Yunpeng YE, Hye-Yeong KIM, Henry(Yiyun) HUANG, Jakub TOCZEK
  • Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications
    Patent number: 8318133
    Abstract: The sensitivity and specificity of the optical modality can be enhanced by the use of highly absorbing compounds as contrast agents. Novel macrocyclic cyanine and indocyanine bioconjugates that absorb and emit light in the near infrared region of electromagnetic spectrum are disclosed. These compounds are especially useful for endoscopic, localized photoacoustic, and sonofluorescence imaging, detection and therapy of tumors and other abnormalities.
    Type: Grant
    Filed: November 2, 2010
    Date of Patent: November 27, 2012
    Assignee: Washington University in St. Louis
    Inventors: Samuel Achilefu, Yunpeng Ye
  • MACROCYCLIC CYANINE AND INDOCYANINE BIOCONJUGATES PROVIDE IMPROVED BIOMEDICAL APPLICATION
    Publication number: 20110123450
    Abstract: The sensitivity and specificity of the optical modality can be enhanced by the use of highly absorbing compounds as contrast agents. Novel macrocyclic cyanine and indocyanine bioconjugates that absorb and emit light in the near infrared region of electromagnetic spectrum are disclosed. These compounds are especially useful for endoscopic, localized photoacoustic, and sonofluorescence imaging, detection and therapy of tumors and other abnormalities.
    Type: Application
    Filed: November 2, 2010
    Publication date: May 26, 2011
    Applicant: THE WASHINGTON UNIVERSITY
    Inventors: Samuel Achilefu, Yunpeng Ye
  • Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications
    Patent number: 7850946
    Abstract: The sensitivity and specificity of the optical modality can be enhanced by the use of highly absorbing compounds as contrast agents. Novel macrocyclic cyanine and indocyanine bioconjugates that absorb and emit light in the near infrared region of electromagnetic spectrum are disclosed. These compounds are especially useful for endoscopic, localized photoacoustic, and sonofluorescence imaging, detection and therapy of tumors and other abnormalities.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: December 14, 2010
    Assignee: Washington University in St. Louis
    Inventors: Samuel Achilefu, Yunpeng Ye
  • Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications
    Publication number: 20070098638
    Abstract: The sensitivity and specificity of the optical modality can be enhanced by the use of highly absorbing compounds as contrast agents. Novel macrocyclic cyanine and indocyanine bioconjugates that absorb and emit light in the near infrated region of electromagnetic spectrum are disclosed. These compounds are especially useful for endoscopic, localized photoacoustic, and sonofluorescence imaging, detection and therapy of tumors and other abnormalities.
    Type: Application
    Filed: June 1, 2004
    Publication date: May 3, 2007
    Inventors: Samuel Achilefu, Yunpeng Ye